Medical test and drug development technologies from UW Bioengineering have spun out into start-ups Nexgenia and Nanosurface Biomedical, with Coulter’s help.
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine. The article explores the history of nanotechnology, its current application and Dr. Stayton’s current work developing a nanotechnology delivery system to treat certain diseases, including liver cancer.
UW researchers, including BioE Professor Patrick Stayton and many collaborators from the UW and Fred Hutchinson Cancer Research Center, have created a protein molecule that can prompt cancer cells infected with the Epstein-Barr virus to self-destruct.
UW Bioengineering professors David Castner, Paul Yager and Patrick Stayton named to Washington State Academy of Sciences.